Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Evogene Ltd. (EVGN) had Weighted-Average Shares Outstanding (Diluted) of 7.23M for the most recently reported fiscal quarter, ending 2025-06-30.
Income Statement Financials | |
$0.88M |
|
$-4.46M |
|
$0.14M |
|
$0.75M |
|
$3.96M |
|
$-3.07M |
|
$-0.46M |
|
$-3.53M |
|
$-3.53M |
|
$-3.53M |
|
$-4.68M |
|
$-4.68M |
|
$-3.53M |
|
$-3.07M |
|
$-2.72M |
|
7.23M |
|
Weighted-Average Shares Outstanding (Diluted) |
7.23M |
$-0.62 |
|
$-0.62 |
|
Balance Sheet Financials | |
$28.64M |
|
$1.36M |
|
$5.28M |
|
$33.93M |
|
$15.19M |
|
-- |
|
$6.36M |
|
$21.55M |
|
$12.38M |
|
$12.38M |
|
$12.38M |
|
8.71M |
|
Cash Flow Statement Financials | |
$-7.48M |
|
$-3.43M |
|
$3.99M |
|
$15.30M |
|
$8.33M |
|
$-6.97M |
|
$0.47M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
1.89 |
|
-- |
|
-- |
|
-- |
|
-- |
|
84.62% |
|
-347.40% |
|
-347.40% |
|
-- |
|
-399.10% |
|
-504.75% |
|
$-7.61M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
0.07 |
|
0.49 |
|
182.24 |
|
-37.83% |
|
-37.83% |
|
-13.80% |
|
-37.83% |
|
$1.42 |
|
$-1.05 |
|
$-1.04 |